节点文献
HPLC-MS/MS法同时测定心通口服液中10种活性成分
Simultaneous determination of 10 active components in Xintong Oral Liquid by HPLC-MS/MS
【摘要】 目的建立高效液相色谱-串联质谱(HPLC-MS/MS)同时测定心通口服液(XOL)中阿魏酸、二苯乙烯苷、葛根素、毛蕊异黄酮苷、柚皮苷、原儿茶醛、丹酚酸B、淫羊藿苷、丹参酮ⅡA、辛弗林的方法。方法采用Phenomenex Luna-C18色谱柱(250 mm×4.6 mm,5μm);乙腈-甲醇-0.02 mol/L乙酸铵溶液为流动相,梯度洗脱,体积流量为0.9 mL/min。质谱条件:ESI源,采用多反应监测模式(MRM),以定量离子对峰面积进行定量。结果阿魏酸、二苯乙烯苷、葛根素、毛蕊异黄酮苷、柚皮苷、原儿茶醛、丹酚酸B、淫羊藿苷、丹参酮ⅡA、辛弗林10种成分的线性范围分别为15.2215 220 ng/mL(r=0.999 3)、19.5219 520 ng/mL(r=0.999 4)、25.4125 410 ng/mL(r=0.999 5)、35.2735 270 ng/mL(r=0.999 2)、30.2830 280 ng/mL(r=0.999 4)、50.1150 110 ng/mL(r=0.999 3)、20.3320 330 ng/mL(r=0.999 2)、25.2225 220ng/mL(r=0.999 6)、25.3625 360 ng/mL(r=0.999 3)、30.2930 290 ng/mL(r=0.999 2),平均加样回收率分别为98.15%、101.84%、99.86%、101.08%、100.52%、100.67%、100.46%、99.43%、100.81%、98.37%,RSD分别为1.04%、0.98%、0.75%、0.87%、1.31%、1.27%、1.64%、1.48%、0.67%、1.16%。10批样品中10种指标成分质量浓度分别为0.2940.319 mg/mL、0.6400.665 mg/mL、4.6714.699 mg/mL、0.2440.264 mg/mL、2.2112.231 mg/mL、0.1800.201 mg/mL、0.3060.324mg/mL、1.5401.564 mg/mL、0.5040.522 mg/mL、0.8090.829 mg/mL。结论该法分离度好,高效快速,可用于XOL的质量控制。
【Abstract】 Objective To establish an HPLC-MS/MS method for the simultaneous determination of ferulic acid, tetrahydroxystilbene glucoside, puerarin, calycosin-7-glucoside, naringin, protocatechuic aldehyde, salvianolic acid B, icariin, tanshinone ⅡA, and synephrine in Xintong Oral Liquid(XOL). Methods The analysis was performed on Phenomenex Luna-C18 column(250 mm × 4.6 mm, 5 μm) by gradient elution of acetonitrile-mehanol-0.02 mol/L ammonium acetate. The flow rate was 0.9 mL/min. MS conditions: electrospray ionization(ESI) and multiple reaction monitoring(MRM) were adopted, the detected peak areas of ion pairs were used for quantitative determination. Results The linear ranges of ferulic acid, tetrahydroxystilbene glucoside, puerarin, calycosin-7-glucoside, naringin, protocatechuic aldehyde, salvianolic acid B, icariin, tanshinone ⅡA, and synephrine were 15.22—15 220(r = 0.999 3), 19.52—19 520(r = 0.999 4), 25.41—25 410(r = 0.999 5), 35.27—35 270(r = 0.999 2), 30.28—30 280(r = 0.999 4), 50.11—50 110(r = 0.999 3), 20.33—20 330(r =0.999 2), 25.22—25 220(r = 0.999 6), 25.36—25 360(r = 0.999 3), and 30.29—30 290 ng/mL(r = 0.999 2). The average recoveries(n = 6) were 98.15%(RSD = 1.04%), 101.84%(RSD = 0.98%), 99.86%(RSD = 0.75%), 101.08%(RSD = 0.87%), 100.52%(RSD =1.31%), 100.67%(RSD = 1.27%), 100.46%(RSD =1.64%), 99.43%(RSD =1.48%), 100.81%(RSD = 0.67%), and 98.37%(RSD =1.16%), respectively. The contents of 10 batches of the 10 active components were 0.294—0.319, 0.640—0.665, 4.671—4.699, 0.244—0.264, 2.211—2.231, 0.180—0.201, 0.306—0.324, 1.540—1.564, 0.504—0.522, and 0.809—0.829 mg/mL. Conclusion This method is simple and rapid, and can be used for the quality control of XOL with satisfactory separation and repeatability.
【Key words】 Xintong Oral Liquid; ferulic acid; tetrahydroxystilbene glucoside; puerarin; calycosin-7-glucoside; naringin; protocatechuic aldehyde; salvianolic acid B; icariin; tanshinone Ⅱ_A; synephrine; HPLC-MS/MS; multiple reaction monitoring;
- 【文献出处】 中草药 ,Chinese Traditional and Herbal Drugs , 编辑部邮箱 ,2017年12期
- 【分类号】O657.63;R286.0
- 【被引频次】6
- 【下载频次】482